MK-507 versus Sezolamide: Comparative Efficacy of Two Topically Active Carbonic Anhydrase Inhibitors

Erik A. Lippa, Joel S. Schuman, Eve J. Higginbotham, Michael A. Kass, Robert N. Weinreb, Gregory L. Skuta, David L. Epstein, Blake Shaw, Daniel J. Holder, Deni A. Deasy, Jacob T. Wilensky

    Research output: Contribution to journalArticlepeer-review

    Fingerprint Dive into the research topics of 'MK-507 versus Sezolamide: Comparative Efficacy of Two Topically Active Carbonic Anhydrase Inhibitors'. Together they form a unique fingerprint.

    Medicine & Life Sciences